Solid Biosciences (SLDB) Capital Expenditures Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 46.88% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 8.97% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 16.27% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | -63.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.31% |
| Dec 31, 2025 | -42.82% |
| Sep 30, 2025 | 23.13% |
| Jun 30, 2025 | 7.98% |
| Mar 31, 2025 | -32.83% |
| Dec 31, 2024 | 58.86% |
| Sep 30, 2024 | -69.68% |
| Jun 30, 2024 | -133.62% |
| Mar 31, 2024 | 62.07% |
| Dec 31, 2023 | 193.37% |
| Sep 30, 2023 | -55.53% |
| Jun 30, 2023 | -36.05% |
| Mar 31, 2023 | 109.54% |
| Dec 31, 2022 | -21.67% |
| Sep 30, 2022 | -37.32% |
| Jun 30, 2022 | -33.43% |
| Mar 31, 2022 | -48.68% |
| Dec 31, 2021 | -47.02% |
| Sep 30, 2021 | 29.17% |
| Jun 30, 2021 | -84.49% |
| Mar 31, 2021 | -67.30% |
| Dec 31, 2020 | 26.74% |
| Sep 30, 2020 | -63.39% |
| Jun 30, 2020 | 32.45% |
| Mar 31, 2020 | 50.92% |